BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32655362)

  • 1.
    Mao Q; Wang X; Chen B; Fan L; Wang S; Zhang Y; Lin X; Cao Y; Wu YC; Ji J; Xu J; Zheng J; Zhang H; Zheng C; Chen W; Cheng W; Luo X; Wang K; Zuo L; Kang L; Li CR; Luo X
    Front Neurosci; 2020; 14():651. PubMed ID: 32655362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant, replicable, and functional associations between KTN1 variants and alcohol and drug codependence.
    Luo X; Guo X; Luo X; Tan Y; Zhang P; Yang K; Xie T; Shi J; Zhang Y; Xu J; Zuo L; Li CR
    Addict Biol; 2021 Mar; 26(2):e12888. PubMed ID: 32115811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KTN1 variants and risk for attention deficit hyperactivity disorder.
    Luo X; Guo X; Tan Y; Zhang Y; Garcia-Milian R; Wang Z; Shi J; Yu T; Ji J; Wang X; Xu J; Zhang H; Zuo L; Lu L; Wang K; Li CR
    Am J Med Genet B Neuropsychiatr Genet; 2020 Jun; 183(4):234-244. PubMed ID: 32190980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Male-specific, replicable and functional roles of genetic variants and cerebral gray matter volumes in ADHD: a gene-wide association study across KTN1 and a region-wide functional validation across brain.
    Luo X; Lin X; Ide JS; Luo X; Zhang Y; Xu J; Wang L; Chen Y; Cheng W; Zheng J; Wang Z; Yu T; Taximaimaiti R; Jing X; Wang X; Cao Y; Tan Y; Li CR
    Child Adolesc Psychiatry Ment Health; 2023 Jan; 17(1):4. PubMed ID: 36609385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A significant, functional and replicable risk KTN1 variant block for schizophrenia.
    Mao Q; Lin X; Yin Q; Liu P; Zhang Y; Qu S; Xu J; Cheng W; Luo X; Kang L; Taximaimaiti R; Zheng C; Zhang H; Wang X; Ren H; Cao Y; Lin J; Luo X
    Sci Rep; 2023 Mar; 13(1):3890. PubMed ID: 36890161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-different interrelationships of rs945270, cerebral gray matter volumes, and attention deficit hyperactivity disorder: a region-wide study across brain.
    Luo X; Fang W; Lin X; Guo X; Chen Y; Tan Y; Wang L; Jing X; Wang X; Zhang Y; Yu T; Ide J; Cao Y; Yang L; Li CR
    Transl Psychiatry; 2022 Jun; 12(1):225. PubMed ID: 35654767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic and transcriptomic assessment of the KTN1 gene in Parkinson's disease risk.
    Moore A; Crea PW; Makarious M; Bandres-Ciga S; Blauwendraat C; Diez-Fairen M
    Neurobiol Aging; 2024 Feb; 134():66-73. PubMed ID: 37992546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voxelwise meta-analysis of gray matter anomalies in Parkinson variant of multiple system atrophy and Parkinson's disease using anatomic likelihood estimation.
    Shao N; Yang J; Shang H
    Neurosci Lett; 2015 Feb; 587():79-86. PubMed ID: 25484255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
    Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
    BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment in Parkinson's disease is associated with decreased P300 amplitude and reduced putamen volume.
    Hünerli D; Emek-Savaş DD; Çavuşoğlu B; Dönmez Çolakoğlu B; Ada E; Yener GG
    Clin Neurophysiol; 2019 Aug; 130(8):1208-1217. PubMed ID: 31163365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microstructural abnormalities of substantia nigra in Parkinson's disease: A neuromelanin sensitive MRI atlas based study.
    Safai A; Prasad S; Chougule T; Saini J; Pal PK; Ingalhalikar M
    Hum Brain Mapp; 2020 Apr; 41(5):1323-1333. PubMed ID: 31778276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic denervation and associated MRI microstructural changes in the nigrostriatal projection in early Parkinson's disease patients.
    López-Aguirre M; Matarazzo M; Blesa J; Monje MHG; Rodríguez-Rojas R; Sánchez-Ferro A; Obeso JA; Pineda-Pardo JA
    NPJ Parkinsons Dis; 2023 Oct; 9(1):144. PubMed ID: 37852988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
    Ahlers-Dannen KE; Spicer MM; Fisher RA
    Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.
    Du G; Lewis MM; Sica C; He L; Connor JR; Kong L; Mailman RB; Huang X
    Mov Disord; 2018 Sep; 33(9):1423-1431. PubMed ID: 29756399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of subthalamic nucleus deep brain stimulation on neuronal spiking activity in the substantia nigra pars compacta in a rat model of Parkinson's disease.
    Sahai S; Effendi ET; Mahoney EC; Tucker HR; Moolick BJ; Mamone G; Mikkilineni S; Gupta M; Nicholson A; Chua FY; Akhtar K; Hirschstein Z; Molho ES; Pilitsis JG; Shin DS
    Neurosci Lett; 2020 Nov; 739():135443. PubMed ID: 33141067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of deep brain stimulation on substantia nigra neurons in a rat model of Parkinson's disease.
    Wu ST; Ma Y; Zhang K; Zhang JG
    Chin Med J (Engl); 2012 Nov; 125(22):4072-5. PubMed ID: 23158145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta.
    Aumann TD; Gantois I; Egan K; Vais A; Tomas D; Drago J; Horne MK
    Exp Neurol; 2008 Oct; 213(2):419-30. PubMed ID: 18680743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinson's disease: a real-time PCR study.
    Bäckman CM; Shan L; Zhang YJ; Hoffer BJ; Leonard S; Troncoso JC; Vonsatel P; Tomac AC
    Mol Cell Endocrinol; 2006 Jun; 252(1-2):160-6. PubMed ID: 16644101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease.
    Lehéricy S; Bardinet E; Poupon C; Vidailhet M; François C
    Mov Disord; 2014 Nov; 29(13):1574-81. PubMed ID: 25308960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different iron deposition patterns in akinetic/rigid-dominant and tremor-dominant Parkinson's disease.
    Xiong W; Li LF; Huang L; Liu Y; Xia ZC; Zhou XX; Tang BS; Guo JF; Lei LF
    Clin Neurol Neurosurg; 2020 Nov; 198():106181. PubMed ID: 33022525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.